David Usharauli is an immunologist and biotech co-founder at Tregeutix, specializing in harnessing regulatory T cells and microbiota for therapeutic development. He focuses on cancer immunotherapy biomarkers and actively engages investors to advance his company's mission. Based in the USA, Usharauli combines scientific expertise with entrepreneurial leadership in the biotech sector.

‌